These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 27773559)

  • 1. Immunophenotypic and genetic characteristics of diffuse large B-cell lymphoma in Taiwan.
    Chang ST; Chen SW; Ho CH; Kuo CC; Sakata S; Takeuchi K; Chuang SS
    J Formos Med Assoc; 2016 Nov; 115(11):961-967. PubMed ID: 27773559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma with composite germinal center and non-germinal center types: A report of two cases.
    Sugitani A; Fukuhara S; Shibata M; Ichihara R; Furukawa H; Maeshima AM
    J Clin Exp Hematop; 2023 Sep; 63(3):181-186. PubMed ID: 37518270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse Large B-Cell Lymphoma in Kenya: MYC, BCL2, and the Cell of Origin.
    Wawire J; Sayed S; Moloo Z; Sohani AR
    J Glob Oncol; 2019 May; 5():1-8. PubMed ID: 31045473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses.
    Maeshima AM; Omatsu M; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
    Cancer Sci; 2008 Sep; 99(9):1760-8. PubMed ID: 18549405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis.
    Ivanova VS; Davies J; Menter T; Wild D; Müller A; Krasniqi F; Stenner F; Papachristofilou A; Dirnhofer S; Tzankov A
    Histopathology; 2024 Feb; 84(3):525-538. PubMed ID: 37965677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 protein frequency in patients with high-risk diffuse large B-cell lymphoma.
    Hallack Neto AE; Siqueira SA; Dulley FL; Chauobah A; Belesso M; Saboia R; Ruiz MA; Chamone DA; Pereira J
    Sao Paulo Med J; 2010 Jan; 128(1):14-7. PubMed ID: 20512275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system lymphoma: Comprehension of cell-of-origin subtypes.
    Rao S; Epari S; Shet TM; Gujral S; Jain H; Bagal B; Senagar M; Shetty P; Moiyadi A; Goda JS; Gupta T
    Indian J Pathol Microbiol; 2023; 66(3):549-555. PubMed ID: 37530337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
    Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
    Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system.
    Gill KZ; Iwamoto F; Allen A; Hoehn D; Murty VV; Alobeid B; Bhagat G
    PLoS One; 2014; 9(12):e114398. PubMed ID: 25479599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of primary central nervous system diffuse large B cell lymphoma: Experience from a Tertiary Center in North India.
    Radotra BD; Parkhi M; Chatterjee D; Yadav BS; Ballari NR; Prakash G; Gupta SK
    Surg Neurol Int; 2020; 11():424. PubMed ID: 33365186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of genetic aberrations in CD10+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization.
    Zhang X; Karnan S; Tagawa H; Suzuki R; Tsuzuki S; Hosokawa Y; Morishima Y; Nakamura S; Seto M
    Cancer Sci; 2004 Oct; 95(10):809-14. PubMed ID: 15504248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Bcl-2 Expression in Non-germinal Center B-cell-Like Diffuse Large B-cell Lymphoma.
    Alford D; Petković I
    Cureus; 2024 Jun; 16(6):e62031. PubMed ID: 38989351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment for 11q and other chromosomal aberrations in large B-cell/high-grade B cell lymphomas of germinal center phenotype lacking BCL2 expression.
    Ho CC; Naresh K; Liu Y; Wu Y; Gopal AK; Eckel AM
    Cancer Genet; 2024 Jun; 284-285():30-33. PubMed ID: 38520765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
    Huang F; Ruan Y; He X; Lian H; Yang J
    World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The altered metabolic pathways of diffuse large B-cell lymphoma not otherwise specified.
    Rodrigues-Fernandes CI; Martins-Chaves RR; Vitório JG; Duarte-Andrade FF; Pereira TDSF; Soares CD; Moreira VR; Lebron YAR; Santos LVS; Lange LC; Canuto GAB; Gomes CC; de Macedo AN; Pontes HAR; Burbano RMR; Martins MD; Pires FR; Mesquita RA; Gomez RS; Santos-Silva AR; Lopes MA; Vargas PA; Fonseca FP
    Leuk Lymphoma; 2023; 64(11):1771-1781. PubMed ID: 37462418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?
    Barton S; Hawkes EA; Wotherspoon A; Cunningham D
    Oncologist; 2012; 17(12):1562-73. PubMed ID: 23086691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Clinical Significance of ki-67, CD10, BCL6, MUM1, c-MYC, and EBV in Diffuse Large B Cell Lymphoma Patients.
    Sadeghipour A; Taha SR; Shariat Zadeh M; Kosari F; Babaheidarian P; Fattahi F; Abdi N; Tajik F
    Appl Immunohistochem Mol Morphol; 2024 Jun; ():. PubMed ID: 38872345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse Large B Cell Lymphoma Cell Line U-2946: Model for MCL1 Inhibitor Testing.
    Quentmeier H; Drexler HG; Hauer V; MacLeod RA; Pommerenke C; Uphoff CC; Zaborski M; Berglund M; Enblad G; Amini RM
    PLoS One; 2016; 11(12):e0167599. PubMed ID: 27907212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression IRF/MUM1>25% Predictor to Three-year Survival of Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era.
    Sofo-Hafizovic A; Chikha A; Gojak R; Hadzimesic ES
    Med Arch; 2016 Oct; 70(5):342-347. PubMed ID: 27994293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa.
    Vest SD; Eriksen PRG; de Groot FA; de Groen RAL; Kleij AHR; Kirkegaard MK; Kamper P; Rasmussen PK; von Buchwald C; de Nully Brown P; Kiilgaard JF; Vermaat JSP; Heegaard S
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.